Fitterfly赢得个人化葡萄糖技术专利 帮助管理糖尿病 Fitterfly wins patent for personalized glucose tech to help manage diabetes.

Fitterfly,PB健康部的一个分部,已经获得其个性化甘蔗反应技术专利,该技术旨在通过提供针对个体食品如何影响血糖水平的特制见解,改善糖尿病管理。 Fitterfly, a division of PB Health, has been granted a patent for its Personalized Glucose Response (PGR) technology, designed to improve diabetes management by offering tailored insights into how individual foods affect blood sugar levels. 创新旨在帮助病人和保健提供者作出更知情的饮食决定,以更好地控制葡萄糖水平,减少糖尿病并发症。 The innovation aims to help patients and healthcare providers make more informed dietary decisions to better control glucose levels and reduce diabetes-related complications. 该专利强调在慢性病管理中日益重视个性化健康解决方案。 The patent underscores a growing focus on personalized health solutions in chronic disease management.